BSECompany Update14h ago · 18 Nov 2026, 05:42 pm
Schedule of Institutional Investors meeting hosted by Investec Confluence
Vijaya Diagnostic Centre Ltd · 543350
✦ AI SummaryMgmt Change
Vijaya Diagnostic Centre Ltd has announced the schedule of an Institutional Investors meeting hosted by Investec Confluence, to be held on December 11, 2026, in Chennai. The meeting will be based on publicly available information and no unpublished price-sensitive information will be shared.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Vijaya Diagnostic Centre Ltd - 543350 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Attachments (1)
📄pdf
Download →
37548b14-d46a-4135-adf1-fd04b0a5ec6e.pdf
View document text
November 18, 2026
The Listing Department The Corporate Relations Department
National Stock Exchange of India Limited, BSE Limited,
NSE Symbol: VIJAYA BSE Scrip Code: 543350
Dear Sir/Madam,
Subject: Intimation of schedule of Analyst / Institutional Investor Meeting
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015, we hereby inform you that the officials of the Company will be interacting
with Institutional Investors/ Analysts as per the details below:
Date / Time of Meeting Analysts / Institutional Type / Mode of Venue of
Investors / Organisation the Meeting the Meeting
Friday, December 11, Investec Confluence Group Meeting / Chennai
2026 from 9:00 A.M. (IST) One on One – In
to 05: 00 P.M. (IST) Person
Note:
1. Discussions will be based on publicly available information and No Unpublished Price Sensitive
Information will be shared during the meetings.
2. The Schedule of the above Analyst / Institutional Investor Meeting is subject to change. The
change may happen due to exigencies on the part of Participants / Company.
3. Investors / Analysts may also subsequently approach the Company for any clarifications
regarding the discussion during the aforesaid meeting.
The above information is also available on the website of the Company:
https://www.vijayadiagnostic.com/investors/disclosure-of-events
Kindly take the same on record.
Thanking you.
Yours faithfully,
for and on behalf of
Vijaya Diagnostic Centre Limited
Narasimha Raju
Chief Financial Officer